Donald B. McCormick

OverviewAI-generated summary

Donald B. McCormick's research focuses on the epidemiological study of infectious diseases, particularly COVID-19, and its impact on public health and healthcare systems. His work has investigated vaccine efficacy, including the effectiveness of booster doses and the duration of immunity against various COVID-19 variants like Delta and Omicron. McCormick has also examined the relationship between the COVID-19 pandemic and mortality rates from other conditions, such as ischemic heart disease, and has explored the uptake of COVID-19 vaccines within specific populations, including K-12 school personnel.

His publications include analyses of COVID-19 incidence and death rates among vaccinated and unvaccinated individuals across multiple U.S. jurisdictions, utilizing large datasets to assess vaccine performance over time and in relation to different variants. McCormick has also evaluated the resource implications of public health tools, such as automated symptom monitoring systems, during the pandemic. His scholarly output is substantial, with a high-impact designation indicated by an h-index of 43 and over 7,400 citations across 361 publications. He collaborates with researchers at the University of Arkansas for Medical Sciences, including Austin Porter and J. Mick Tilford.

Metrics

• h-index: 43
• Publications: 361
• Citations: 7,470